SPECT technique for visualization of cerebral dopamine D2 receptors.
P
P
Konig
M K
MK
Benzer
H
H
Fritzche
D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001549:Benzamides / Q000378:metabolism; D001921:Brain / Q000000981:diagnostic imaging* / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D011569:Psychiatric Status Rating Scales; D011759:Pyrrolidines / Q000378:metabolism; D011954:Receptors, Dopamine / Q000032:analysis* / Q000187:drug effects / Q000378:metabolism; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism; D012565:Schizophrenic Psychology; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*
D014150:Antipsychotic Agents; D001549:Benzamides; D011759:Pyrrolidines; D011954:Receptors, Dopamine; C055743:3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide